NCT02965924View on ClinicalTrials.gov

Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2016

Primary Completion Date

October 1, 2018

Study Completion Date

October 1, 2018

Conditions
Assess Phenylephrine on EVP and IOP
Interventions
DRUG

Phenylephrine 2.5%

Instilling phenylephrine 2.5% eye drop

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT02965924 - Effect of Topical Phenylephrine 2.5% on EVP in Normal Human Eyes | Biotech Hunter | Biotech Hunter